+1 (704) 266-3234

Global Cancer Immunotherapy Drug Discovery Outsourcing Market Insights, Forecast To 2028

Published on: Apr 2022 | From USD $2900 | Published By: QY RESEARCH | Number Of Pages: 105

Cancer Immunotherapy Drug Discovery Outsourcing market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Cancer Immunotherapy Drug Discovery Outsourcing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
By Drug Type
By Cancer Type
Segment by Application
Lung
Breast
Colorectal
Melanoma
Prostate
Head and Neck
Ovarian
Pancreatic
By Company
Aquila BioMedical
BPS Bioscience, Inc.
Celentyx Ltd
Crown Bioscience, Inc.
DiscoverX Corporation
Explicyte
Genscript Biotech Corporation
HD Biosciences Co.
Horizon Discovery Group PLC
ImmunXperts SA
Molecular Imaging, Inc.
Promega Corporation,Personalis, Inc.
STC Biologics
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 By Drug Type
1.2.3 By Cancer Type
1.3 Market by Application
1.3.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Lung
1.3.3 Breast
1.3.4 Colorectal
1.3.5 Melanoma
1.3.6 Prostate
1.3.7 Head and Neck
1.3.8 Ovarian
1.3.9 Pancreatic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Perspective (2017-2028)
2.2 Cancer Immunotherapy Drug Discovery Outsourcing Growth Trends by Region
2.2.1 Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Cancer Immunotherapy Drug Discovery Outsourcing Historic Market Size by Region (2017-2022)
2.2.3 Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Region (2023-2028)
2.3 Cancer Immunotherapy Drug Discovery Outsourcing Market Dynamics
2.3.1 Cancer Immunotherapy Drug Discovery Outsourcing Industry Trends
2.3.2 Cancer Immunotherapy Drug Discovery Outsourcing Market Drivers
2.3.3 Cancer Immunotherapy Drug Discovery Outsourcing Market Challenges
2.3.4 Cancer Immunotherapy Drug Discovery Outsourcing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Immunotherapy Drug Discovery Outsourcing Players by Revenue
3.1.1 Global Top Cancer Immunotherapy Drug Discovery Outsourcing Players by Revenue (2017-2022)
3.1.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Players (2017-2022)
3.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cancer Immunotherapy Drug Discovery Outsourcing Revenue
3.4 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Concentration Ratio
3.4.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Immunotherapy Drug Discovery Outsourcing Revenue in 2021
3.5 Cancer Immunotherapy Drug Discovery Outsourcing Key Players Head office and Area Served
3.6 Key Players Cancer Immunotherapy Drug Discovery Outsourcing Product Solution and Service
3.7 Date of Enter into Cancer Immunotherapy Drug Discovery Outsourcing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Immunotherapy Drug Discovery Outsourcing Breakdown Data by Type
4.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Historic Market Size by Type (2017-2022)
4.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Type (2023-2028)
5 Cancer Immunotherapy Drug Discovery Outsourcing Breakdown Data by Application
5.1 Global Cancer Immunotherapy Drug Discovery Outsourcing Historic Market Size by Application (2017-2022)
5.2 Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2017-2028)
6.2 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
6.2.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2017-2022)
6.2.2 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2023-2028)
6.2.3 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2017-2028)
6.3 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application
6.3.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2017-2022)
6.3.2 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2023-2028)
6.3.3 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2017-2028)
6.4 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country
6.4.1 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2017-2022)
6.4.2 North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2017-2028)
7.2 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
7.2.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2017-2022)
7.2.2 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2023-2028)
7.2.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2017-2028)
7.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application
7.3.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2017-2022)
7.3.2 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2023-2028)
7.3.3 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2017-2028)
7.4 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country
7.4.1 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2017-2022)
7.4.2 Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2017-2028)
8.2 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
8.2.1 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2017-2028)
8.3 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application
8.3.1 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2017-2028)
8.4 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region
8.4.1 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2017-2028)
9.2 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
9.2.1 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2017-2022)
9.2.2 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2023-2028)
9.2.3 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2017-2028)
9.3 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application
9.3.1 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2017-2022)
9.3.2 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2023-2028)
9.3.3 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2017-2028)
9.4 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country
9.4.1 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2017-2022)
9.4.2 Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size (2017-2028)
10.2 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type
10.2.1 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type (2017-2028)
10.3 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application
10.3.1 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application (2017-2028)
10.4 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country
10.4.1 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Aquila BioMedical
11.1.1 Aquila BioMedical Company Details
11.1.2 Aquila BioMedical Business Overview
11.1.3 Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.1.4 Aquila BioMedical Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
11.1.5 Aquila BioMedical Recent Developments
11.2 BPS Bioscience, Inc.
11.2.1 BPS Bioscience, Inc. Company Details
11.2.2 BPS Bioscience, Inc. Business Overview
11.2.3 BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.2.4 BPS Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
11.2.5 BPS Bioscience, Inc. Recent Developments
11.3 Celentyx Ltd
11.3.1 Celentyx Ltd Company Details
11.3.2 Celentyx Ltd Business Overview
11.3.3 Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.3.4 Celentyx Ltd Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
11.3.5 Celentyx Ltd Recent Developments
11.4 Crown Bioscience, Inc.
11.4.1 Crown Bioscience, Inc. Company Details
11.4.2 Crown Bioscience, Inc. Business Overview
11.4.3 Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.4.4 Crown Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
11.4.5 Crown Bioscience, Inc. Recent Developments
11.5 DiscoverX Corporation
11.5.1 DiscoverX Corporation Company Details
11.5.2 DiscoverX Corporation Business Overview
11.5.3 DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.5.4 DiscoverX Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
11.5.5 DiscoverX Corporation Recent Developments
11.6 Explicyte
11.6.1 Explicyte Company Details
11.6.2 Explicyte Business Overview
11.6.3 Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.6.4 Explicyte Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
11.6.5 Explicyte Recent Developments
11.7 Genscript Biotech Corporation
11.7.1 Genscript Biotech Corporation Company Details
11.7.2 Genscript Biotech Corporation Business Overview
11.7.3 Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.7.4 Genscript Biotech Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
11.7.5 Genscript Biotech Corporation Recent Developments
11.8 HD Biosciences Co.
11.8.1 HD Biosciences Co. Company Details
11.8.2 HD Biosciences Co. Business Overview
11.8.3 HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.8.4 HD Biosciences Co. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
11.8.5 HD Biosciences Co. Recent Developments
11.9 Horizon Discovery Group PLC
11.9.1 Horizon Discovery Group PLC Company Details
11.9.2 Horizon Discovery Group PLC Business Overview
11.9.3 Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.9.4 Horizon Discovery Group PLC Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
11.9.5 Horizon Discovery Group PLC Recent Developments
11.10 ImmunXperts SA
11.10.1 ImmunXperts SA Company Details
11.10.2 ImmunXperts SA Business Overview
11.10.3 ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.10.4 ImmunXperts SA Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
11.10.5 ImmunXperts SA Recent Developments
11.11 Molecular Imaging, Inc.
11.11.1 Molecular Imaging, Inc. Company Details
11.11.2 Molecular Imaging, Inc. Business Overview
11.11.3 Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.11.4 Molecular Imaging, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
11.11.5 Molecular Imaging, Inc. Recent Developments
11.12 Promega Corporation,Personalis, Inc.
11.12.1 Promega Corporation,Personalis, Inc. Company Details
11.12.2 Promega Corporation,Personalis, Inc. Business Overview
11.12.3 Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.12.4 Promega Corporation,Personalis, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
11.12.5 Promega Corporation,Personalis, Inc. Recent Developments
11.13 STC Biologics
11.13.1 STC Biologics Company Details
11.13.2 STC Biologics Business Overview
11.13.3 STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Introduction
11.13.4 STC Biologics Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
11.13.5 STC Biologics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Type I
Table 3. Key Players of Type II
Table 4. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Region (2017-2022)
Table 8. Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Region (2023-2028)
Table 10. Cancer Immunotherapy Drug Discovery Outsourcing Market Trends
Table 11. Cancer Immunotherapy Drug Discovery Outsourcing Market Drivers
Table 12. Cancer Immunotherapy Drug Discovery Outsourcing Market Challenges
Table 13. Cancer Immunotherapy Drug Discovery Outsourcing Market Restraints
Table 14. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Share by Players (2017-2022)
Table 16. Global Top Cancer Immunotherapy Drug Discovery Outsourcing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Immunotherapy Drug Discovery Outsourcing as of 2021)
Table 17. Ranking of Global Top Cancer Immunotherapy Drug Discovery Outsourcing Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Cancer Immunotherapy Drug Discovery Outsourcing Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Cancer Immunotherapy Drug Discovery Outsourcing Product Solution and Service
Table 21. Date of Enter into Cancer Immunotherapy Drug Discovery Outsourcing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Type (2017-2022)
Table 25. Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Market Share by Type (2023-2028)
Table 27. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Share by Application (2017-2022)
Table 29. Global Cancer Immunotherapy Drug Discovery Outsourcing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Cancer Immunotherapy Drug Discovery Outsourcing Revenue Share by Application (2023-2028)
Table 31. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size by Country (2023-2028) & (US$ Million)
Table 61. Aquila BioMedical Company Details
Table 62. Aquila BioMedical Business Overview
Table 63. Aquila BioMedical Cancer Immunotherapy Drug Discovery Outsourcing Product
Table 64. Aquila BioMedical Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022) & (US$ Million)
Table 65. Aquila BioMedical Recent Developments
Table 66. BPS Bioscience, Inc. Company Details
Table 67. BPS Bioscience, Inc. Business Overview
Table 68. BPS Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product
Table 69. BPS Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022) & (US$ Million)
Table 70. BPS Bioscience, Inc. Recent Developments
Table 71. Celentyx Ltd Company Details
Table 72. Celentyx Ltd Business Overview
Table 73. Celentyx Ltd Cancer Immunotherapy Drug Discovery Outsourcing Product
Table 74. Celentyx Ltd Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022) & (US$ Million)
Table 75. Celentyx Ltd Recent Developments
Table 76. Crown Bioscience, Inc. Company Details
Table 77. Crown Bioscience, Inc. Business Overview
Table 78. Crown Bioscience, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product
Table 79. Crown Bioscience, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022) & (US$ Million)
Table 80. Crown Bioscience, Inc. Recent Developments
Table 81. DiscoverX Corporation Company Details
Table 82. DiscoverX Corporation Business Overview
Table 83. DiscoverX Corporation Cancer Immunotherapy Drug Discovery Outsourcing Product
Table 84. DiscoverX Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022) & (US$ Million)
Table 85. DiscoverX Corporation Recent Developments
Table 86. Explicyte Company Details
Table 87. Explicyte Business Overview
Table 88. Explicyte Cancer Immunotherapy Drug Discovery Outsourcing Product
Table 89. Explicyte Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022) & (US$ Million)
Table 90. Explicyte Recent Developments
Table 91. Genscript Biotech Corporation Company Details
Table 92. Genscript Biotech Corporation Business Overview
Table 93. Genscript Biotech Corporation Cancer Immunotherapy Drug Discovery Outsourcing Product
Table 94. Genscript Biotech Corporation Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022) & (US$ Million)
Table 95. Genscript Biotech Corporation Recent Developments
Table 96. HD Biosciences Co. Company Details
Table 97. HD Biosciences Co. Business Overview
Table 98. HD Biosciences Co. Cancer Immunotherapy Drug Discovery Outsourcing Product
Table 99. HD Biosciences Co. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022) & (US$ Million)
Table 100. HD Biosciences Co. Recent Developments
Table 101. Horizon Discovery Group PLC Company Details
Table 102. Horizon Discovery Group PLC Business Overview
Table 103. Horizon Discovery Group PLC Cancer Immunotherapy Drug Discovery Outsourcing Product
Table 104. Horizon Discovery Group PLC Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022) & (US$ Million)
Table 105. Horizon Discovery Group PLC Recent Developments
Table 106. ImmunXperts SA Company Details
Table 107. ImmunXperts SA Business Overview
Table 108. ImmunXperts SA Cancer Immunotherapy Drug Discovery Outsourcing Product
Table 109. ImmunXperts SA Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022) & (US$ Million)
Table 110. ImmunXperts SA Recent Developments
Table 111. Molecular Imaging, Inc. Company Details
Table 112. Molecular Imaging, Inc. Business Overview
Table 113. Molecular Imaging, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product
Table 114. Molecular Imaging, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022) & (US$ Million)
Table 115. Molecular Imaging, Inc. Recent Developments
Table 116. Promega Corporation,Personalis, Inc. Company Details
Table 117. Promega Corporation,Personalis, Inc. Business Overview
Table 118. Promega Corporation,Personalis, Inc. Cancer Immunotherapy Drug Discovery Outsourcing Product
Table 119. Promega Corporation,Personalis, Inc. Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022) & (US$ Million)
Table 120. Promega Corporation,Personalis, Inc. Recent Developments
Table 121. STC Biologics Company Details
Table 122. STC Biologics Business Overview
Table 123. STC Biologics Cancer Immunotherapy Drug Discovery Outsourcing Product
Table 124. STC Biologics Revenue in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022) & (US$ Million)
Table 125. STC Biologics Recent Developments
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Type: 2021 VS 2028
Figure 2. Type I Features
Figure 3. Type II Features
Figure 4. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Application: 2021 VS 2028
Figure 5. Lung Case Studies
Figure 6. Breast Case Studies
Figure 7. Colorectal Case Studies
Figure 8. Melanoma Case Studies
Figure 9. Prostate Case Studies
Figure 10. Head and Neck Case Studies
Figure 11. Ovarian Case Studies
Figure 12. Pancreatic Case Studies
Figure 13. Cancer Immunotherapy Drug Discovery Outsourcing Report Years Considered
Figure 14. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 15. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Region: 2021 VS 2028
Figure 17. Global Cancer Immunotherapy Drug Discovery Outsourcing Market Share by Players in 2021
Figure 18. Global Top Cancer Immunotherapy Drug Discovery Outsourcing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Immunotherapy Drug Discovery Outsourcing as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Cancer Immunotherapy Drug Discovery Outsourcing Revenue in 2021
Figure 20. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY (2017-2028) & (US$ Million)
Figure 21. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Type (2017-2028)
Figure 22. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Application (2017-2028)
Figure 23. North America Cancer Immunotherapy Drug Discovery Outsourcing Market Size Share by Country (2017-2028)
Figure 24. United States Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Canada Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY (2017-2028) & (US$ Million)
Figure 27. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Type (2017-2028)
Figure 28. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Application (2017-2028)
Figure 29. Europe Cancer Immunotherapy Drug Discovery Outsourcing Market Size Share by Country (2017-2028)
Figure 30. Germany Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. France Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. U.K. Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Italy Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Russia Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Nordic Countries Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Asia-Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY (2017-2028) & (US$ Million)
Figure 37. Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Type (2017-2028)
Figure 38. Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Application (2017-2028)
Figure 39. Asia Pacific Cancer Immunotherapy Drug Discovery Outsourcing Market Size Share by Region (2017-2028)
Figure 40. China Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Japan Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. South Korea Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Southeast Asia Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. India Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Australia Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 46. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY (2017-2028) & (US$ Million)
Figure 47. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Type (2017-2028)
Figure 48. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Application (2017-2028)
Figure 49. Latin America Cancer Immunotherapy Drug Discovery Outsourcing Market Size Share by Country (2017-2028)
Figure 50. Mexico Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Brazil Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. Middle East & Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY (2017-2028) & (US$ Million)
Figure 53. Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Type (2017-2028)
Figure 54. Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size Market Share by Application (2017-2028)
Figure 55. Middle East and Africa Cancer Immunotherapy Drug Discovery Outsourcing Market Size Share by Country (2017-2028)
Figure 56. Turkey Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. Saudi Arabia Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. UAE Cancer Immunotherapy Drug Discovery Outsourcing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 59. Aquila BioMedical Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
Figure 60. BPS Bioscience, Inc. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
Figure 61. Celentyx Ltd Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
Figure 62. Crown Bioscience, Inc. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
Figure 63. DiscoverX Corporation Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
Figure 64. Explicyte Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
Figure 65. Genscript Biotech Corporation Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
Figure 66. HD Biosciences Co. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
Figure 67. Horizon Discovery Group PLC Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
Figure 68. ImmunXperts SA Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
Figure 69. Molecular Imaging, Inc. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
Figure 70. Promega Corporation,Personalis, Inc. Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
Figure 71. STC Biologics Revenue Growth Rate in Cancer Immunotherapy Drug Discovery Outsourcing Business (2017-2022)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

USD $2900
USD $3900
USD $4900
COVID-19
Offer

WHY US?

  • Why Us In-depth database
    Our Report’s database covers almost all topics of all regions over the Globe..
  • Why Us Recognised publishing sources
    Tie ups with top publishers around the globe.
  • Why Us Customer Support
    Complete pre and post sales support.
  • Why Us Safe & Secure
    Complete secure payment process.